title: Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenografts.
abstract: The overall purpose of this study was to establish human head and neck squamous cell carcinoma (HNSCC) xenografts in mice by transplantation of surgical tumor tissue and to characterize the growth, histologic and vascular properties of these xenografts. Primary surgical specimens of HNSCC were xenografted into eight-to-twelve week old severe combined immunodeficiency (SCID) mice. Histologic features of primary HNSCC specimens, initial and established xenografts were compared for tumors established from three different head and neck subsites, namely, oral cavity, larynx and base of tongue (one tumor per site). Growth rates of xenografts were compared along with magnetic resonance imaging (MRI) measures of tumor vascularity and correlative CD31-immunostaining. Initial and established xenografts from all three sites demonstrated a squamous phenotype similar to the original patient tumor histology. Established xenografts of oral cavity and larynx exhibited increased keratinization (H&E) compared to initial xenografts and the primary tumor. No differences in tumor growth rates were observed between established xenografts from the different subsites. Xenografts established from SCC of the larynx exhibited increased microvessel density and lumen area (CD31 staining) along with enhanced permeability to the MR contrast agent compared to oral cavity and base of tongue tumors. Our results show that the combination of non-invasive imaging along with histologic evaluation of patient tumor xenografts offers a valuable platform for preclinical investigations in head and neck cancer. However, it is important to recognize the influence of tumor-host interactions on the histologic phenotype of transplanted tumors.
authors.affiliation: Departments of Cancer Biology and Dentistry and Maxillofacial Prosthetics, Roswell Park Cancer Institute, Buffalo, NY, USA. Mukund.Seshadri@roswellpark.org
authors.forename: Mukund
authors.initials: M
authors.lastname: Seshadri
authors.forename: Mihai
authors.initials: M
authors.lastname: Merzianu
authors.forename: Haikuo
authors.initials: H
authors.lastname: Tang
authors.forename: Nestor R
authors.initials: NR
authors.lastname: Rigual
authors.forename: Maureen
authors.initials: M
authors.lastname: Sullivan
authors.forename: Thom R
authors.initials: TR
authors.lastname: Loree
authors.forename: Saurin R
authors.initials: SR
authors.lastname: Popat
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Repasky
authors.forename: Bonnie L
authors.initials: BL
authors.lastname: Hylander
mesh_terms: D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000473:pathology*; D006258:Head and Neck Neoplasms / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007124:Immunoenzyme Techniques; D008279:Magnetic Resonance Imaging; D051379:Mice; D016513:Mice, SCID; D010641:Phenotype; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000378:metabolism; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured / Q000637:transplantation
chemical_list: D019408:Platelet Endothelial Cell Adhesion Molecule-1